Evidence map›Paper›PMID 27980211›Full record

ArticleScience (New York, N.Y.)2016

Engineering extrinsic disorder to control protein activity in living cells.

Onur Dagliyan, Miroslaw Tarnawski, Pei-Hsuan Chu, David Shirvanyants, Ilme Schlichting, Nikolay V Dokholyan, Klaus M Hahn

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Allosteric Biosensors Unravel GTPase-Effector Feedback.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  14. Review
  15. Review
  16. Review
  17. Optogenetic enzymes: A deep dive into design and impact.Current opinion in structural biology · 2025
    Review
  18. Article
  19. Article
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Onur DagliyanProgram in Molecular and Cellular Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Miroslaw TarnawskiDepartment of Biomolecular Mechanisms, Max Planck Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany.
Pei-Hsuan ChuDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
David ShirvanyantsDepartment of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Ilme SchlichtingDepartment of Biomolecular Mechanisms, Max Planck Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany.
Nikolay V DokholyanProgram in Molecular and Cellular Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. khahn@med.unc.edu dokh@email.unc.edu.
Klaus M HahnDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. khahn@med.unc.edu dokh@email.unc.edu.

Funding

INTERACTIVE GRAPHICS FOR MOLECULAR STUDIES &MICROSCOPYP41EB002025 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUPERFINE, RICHARD · 2003 to 2019
$16.9M
Spatio-temporal dynamics of GEF-GTPase networksP01GM103723 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAHN, KLAUS M. · 2013 to 2017
$5.5M
Mechanisms Of Cell Migration On 3D Aligned MatricesR01CA142833 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI FRIEDL, ANDREAS, HAHN, KLAUS M. · 2010 to 2020
$3.4M
Protein Misfolding and AggregationR01GM080742 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DOKHOLYAN, NIKOLAY · 2007 to 2015
$2.8M
Mechanisms of PAK1 activation, signaling and tumor resistanceR01CA175747 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J., HAHN, KLAUS M. · 2014 to 2018
$1.8M
Mechanisms of vinculin activation and force transmissionR01GM115597 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CAMPBELL, SHARON L · 2016 to 2019
$1.6M
NCI NIH HHS R01 CA142833NCI NIH HHS R01 CA175747NIBIB NIH HHS P41 EB002025NIGMS NIH HHS P01 GM103723NIGMS NIH HHS R01 GM080742NIGMS NIH HHS R01 GM115597
6 · The paper itself

Abstract

Optogenetic and chemogenetic control of proteins has revealed otherwise inaccessible facets of signaling dynamics. Here, we use light- or ligand-sensitive domains to modulate the structural disorder of diverse proteins, thereby generating robust allosteric switches. Sensory domains were inserted into nonconserved, surface-exposed loops that were tight and identified computationally as allosterically coupled to active sites. Allosteric switches introduced into motility signaling proteins (kinases, guanosine triphosphatases, and guanine exchange factors) controlled conversion between conformations closely resembling natural active and inactive states, as well as modulated the morphodynamics of living cells. Our results illustrate a broadly applicable approach to design physiological protein switches.

Indexed as

LightProtein Engineeringsrc-Family KinasesAllosteric RegulationAllosteric SiteCatalytic DomainEnzyme ActivationGTP PhosphohydrolasesGuanine Nucleotide Exchange FactorsHEK293 CellsHumansLigandsOptogeneticsProtein DomainsProto-Oncogene Proteins c-vavSignal TransductionGTP PhosphohydrolasesGuanine Nucleotide Exchange FactorsLigandsProto-Oncogene Proteins c-vavsrc-Family KinasesVAV2 protein, human

Identifiers

PMID27980211
PMCPMC5362825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.